RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

No results found for given criteria.

Related Reports

Market Research Reports provided by reports.iptechex.com
Epidemiology: Renal Cell Cancer – Incident cases set to soar
Mar 2011 - 29 pages - $3,800
Transitional Cell Cancer - Pipeline Review, Q4 2010
Dec 2010 - 29 pages - $500
Successes and Failures for Avastin (Bevacizumab) mean Mixed News for the Blockbuster Drug in the Oncology Therapeutics Market
May 2011 - 7 pages - $500
Tivozanib: Newer VEGF Inhibitors Represent A Paradigm Shift In Renal Cell Carcinoma Therapy
Feb 2011 - 6 pages - $500
Transitional Cell Cancer Global Clinical Trials Review, Q4, 2010
Dec 2010 - 40 pages - $1,000
Kidney Cancer Therapy Area Pipeline Report
Nov 2010 - 485 pages - $1,495
Renal Cell Carcinoma - Pipeline Review, Q1 2011
Jan 2011 - 82 pages - $500
Prostate Cancer Drug Discoveries: What the Future Holds
Nov 2009 - 160 pages - $2,265
Kidney Cancer - Pipeline Review, Q3 2011
Jul 2011 - 228 pages - $500
Lung Cancer and Non-Small Cell Lung Cancer Therapy Area Pipeline Report
Nov 2010 - 1535 pages - $1,495
More Related Market Research Reports >>>

Your selection

Industry sector
Research tools del
Antibodies del
Therapeutic target
Oncology del
Kidney cancer del
Transitional cell cancer of the renal pe del
Development phase
Phase I del

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us